Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial
Rheumatol Ther
.
2024 Aug;11(4):1063.
doi: 10.1007/s40744-024-00686-x.
Authors
Kurt de Vlam
1
,
Walter P Maksymowych
2
,
Gaia Gallo
3
,
Proton Rahman
4
,
Philip Mease
5
,
Venkatesh Krishnan
3
,
Conor J McVeigh
3
,
Jeffrey Lisse
3
,
Danting Zhu
3
,
Rebecca J Bolce
3
,
Philip G Conaghan
6
Affiliations
1
University Hospital Leuven, Leuven, Belgium.
[email protected]
.
2
Department of Medicine, Division of Rheumatology at the University of Alberta, Edmonton, Alberta, Canada.
3
Eli Lilly and Company, Indianapolis, USA.
4
Department of Medicine, Memorial University, St. John's, Newfoundland, A1C 5B8, Canada.
5
Swedish Medical Center/Providence St, Joseph Health and University of Washington, Seattle, Washington, USA.
6
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK.
PMID:
38874859
PMCID:
PMC11260269
DOI:
10.1007/s40744-024-00686-x
No abstract available
Publication types
Published Erratum